ÂÜÀòÂÒÂ×

Debobrato Das, Ph.D., is an accomplished expert in bioengineering with extensive experience in the pharmaceutical industry and research academia. Currently serving as Associate Director at BioMarin Pharmaceutical Inc. since August 2021, Debobrato has previously held roles at the Novartis Institutes for BioMedical Research as Principal Scientist and Postdoctoral Scholar, focusing on chemical biology and therapeutics. Academic experiences include a Ph.D. in Bioengineering from the University of Washington and a Bachelor’s and Master’s in Bioengineering from UCLA. Debobrato is also pursuing a Certificate in Disruptive Strategy from Harvard Business School Online. Key achievements include the development of a biomimetic calcium-phosphate nanoparticle delivery system for targeted gene delivery and bone growth regulation.